IMDX vs XLK
Insight Molecular Diagnostics Inc. (IMDX) versus Technology Select Sector SPDR® Fund (XLK) — a side-by-side from cached financials, not a winner call.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Technology Select Sector SPDR® Fund (XLK) common stock listed on US.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
XLK does not have a complete income-statement cache yet.
IMDX currently screens at market cap $0. XLK currently screens at market cap $0.
Not investment advice. Open the IMDX and XLK stock pages for the full models.
Not investment advice.